Jansen metaphyseal chondrodysplasia: analysis of craniofacial manifestations
Jansen metaphyseal chondrodysplasia (JMC) is an ultra-rare disorder caused by constitutive activation of parathyroid hormone type 1 receptor (PTH1R). We sought to characterize the craniofacial phenotype of patients with the disease. Six patients with genetically confirmed JMC underwent comprehensive craniofacial phenotyping revealing a distinct facial appearance that prompted a cephalometric analysis demonstrating a pattern of mandibular retrognathia. Oral examination was notable for flat and shallow palate, delayed eruption pattern, and impacted maxillary teeth. Subclinical and/or mild hearing loss was noted in 4 of 5 patients studied. The most common etiology was conductive, likely due to overcrowding of epitympanum which impedes the normal vibration of ossicles to sound. Paranasal sinus obliteration was noted in 5 of 6 patients. Computed tomography (CT) scan evaluation of craniofacial bones revealed bilaterally symmetric expansile lesions with predominant involvement of neural crest cell (NCC)-derived bones. Bilateral narrowing of facial nerve canals, particularly at the labyrinthine segment, was seen in 5 of 6 patients when compared to age-matched controls; 1 patient presented with progressive facial nerve palsy. Sagittal suture craniosynostosis was present in 5 of 6 patients-one of whom had a history of cranial reconstruction for pansynostosis in infancy. All patients demonstrated a significant degree of upper airway stenosis, as well as a more anterior hyoid bone displacement. Two patients had a diagnosis of obstructive sleep apnea. 18F-NaF Positron-emission tomography (PET)-CT revealed increased uptake associated with the skull base and gnathic bones in all patients. In conclusion, this first detailed systematic evaluation of the craniofacial phenotype of patients with JMC demonstrates a distinct and pronounced phenotype that predominantly affects the NCC-derived cranial bones indicating a critical role of PTH1R signaling in their development. These affects can result in significant disease-related morbidity, include hearing loss, nerve compression, craniosynostosis, dentoskeletal malocclusion, and airway compromise; all of which require close monitoring.
Authors
- Rachel I. Gafni (ORCID: https://orcid.org/0000-0002-7970-3491)
- Lee S. Weinstein (ORCID: https://orcid.org/0000-0002-1899-5152)
- Alison M Boyce (ORCID: https://orcid.org/0000-0003-2987-3887)
- Konstantinia Almpani (ORCID: https://orcid.org/0000-0001-7558-6796)
- Faraz Farhadi (ORCID: https://orcid.org/0000-0002-6958-0811)
- Hung Jeffrey Kim
- Kelly Lauter Roszko (ORCID: https://orcid.org/0000-0002-0284-5299)
- Carlos R. Ferreira (ORCID: https://orcid.org/0000-0002-2697-1046)
- Harald Jüppner
- Christopher Zalewski (ORCID: https://orcid.org/0000-0002-9196-0589)
- Michael T. Collins (ORCID: https://orcid.org/0000-0003-3676-7644)
- Smita Jha (ORCID: https://orcid.org/0000-0001-9201-3340)
- Fiona Obiezu (ORCID: https://orcid.org/0009-0003-2652-9965)
- Emily Y. Chu (ORCID: https://orcid.org/0000-0001-7763-2928)
- Janice S. Lee (ORCID: https://orcid.org/0000-0001-5164-5958)
- Golnar Jahanmir
Institutions
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- National Institute of Dental and Craniofacial Research (US)
- National Human Genome Research Institute (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- National Institutes of Health Clinical Center (US)
- National Institute on Deafness and Other Communication Disorders (US)
Publication Details
- Journal
- JBMR Plus
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1093/jbmrpl/ziae156
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Human Genome Research Institute
- National Institute on Deafness and Other Communication Disorders
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Dental and Craniofacial Research
- NIH Clinical Center
- National Center for Advancing Translational Sciences